Switch to:

Teva Pharmaceutical Industries EV-to-Revenue

: 2.25 (As of Today)
View and export this data going back to 1990. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Teva Pharmaceutical Industries's enterprise value is $38,195 Mil. Teva Pharmaceutical Industries's Revenue for the trailing twelve months (TTM) ended in Mar. 2020 was $16,950 Mil. Therefore, Teva Pharmaceutical Industries's EV-to-Revenue for today is 2.25.

NYSE:TEVA' s EV-to-Revenue Range Over the Past 10 Years
Min: 2   Med: 2.9   Max: 4.8
Current: 2.24

2
4.8

During the past 13 years, the highest EV-to-Revenue of Teva Pharmaceutical Industries was 4.80. The lowest was 2.00. And the median was 2.90.

NYSE:TEVA's EV-to-Revenue is ranked higher than
59% of the 956 Companies
in the Drug Manufacturers industry.

( Industry Median: 2.91 vs. NYSE:TEVA: 2.24 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2020-07-15), Teva Pharmaceutical Industries's stock price is $11.72. Teva Pharmaceutical Industries's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2020 was $15.51. Therefore, Teva Pharmaceutical Industries's PS Ratio for today is 0.76.


Teva Pharmaceutical Industries EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Teva Pharmaceutical Industries Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.73 3.68 2.55 2.56 2.23

Teva Pharmaceutical Industries Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.66 2.29 2.08 2.23 2.13

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Teva Pharmaceutical Industries EV-to-Revenue Distribution

* The bar in red indicates where Teva Pharmaceutical Industries's EV-to-Revenue falls into.



Teva Pharmaceutical Industries EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Teva Pharmaceutical Industries's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=38194.793/16950
=2.25

Teva Pharmaceutical Industries's current Enterprise Value is $38,195 Mil.
Teva Pharmaceutical Industries's Revenue for the trailing twelve months (TTM) ended in Mar. 2020 was 4337 (Jun. 2019 ) + 4264 (Sep. 2019 ) + 3992 (Dec. 2019 ) + 4357 (Mar. 2020 ) = $16,950 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Teva Pharmaceutical Industries  (NYSE:TEVA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Teva Pharmaceutical Industries's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=11.72/15.511
=0.76

Teva Pharmaceutical Industries's share price for today is $11.72.
Teva Pharmaceutical Industries's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2020 was 3.972 (Jun. 2019 ) + 3.905 (Sep. 2019 ) + 3.659 (Dec. 2019 ) + 3.975 (Mar. 2020 ) = $15.51.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Teva Pharmaceutical Industries EV-to-Revenue Related Terms


Teva Pharmaceutical Industries EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)